rs3025694

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004380.3(CREBBP):​c.2784G>A​(p.Pro928Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0159 in 1,613,890 control chromosomes in the GnomAD database, including 1,513 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 168 hom., cov: 31)
Exomes 𝑓: 0.015 ( 1345 hom. )

Consequence

CREBBP
NM_004380.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.47

Publications

15 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 16-3770666-C-T is Benign according to our data. Variant chr16-3770666-C-T is described in ClinVar as Benign. ClinVar VariationId is 158350.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.47 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.2784G>Ap.Pro928Pro
synonymous
Exon 14 of 31NP_004371.2Q92793-1
CREBBP
NM_001079846.1
c.2670G>Ap.Pro890Pro
synonymous
Exon 13 of 30NP_001073315.1Q92793-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.2784G>Ap.Pro928Pro
synonymous
Exon 14 of 31ENSP00000262367.5Q92793-1
CREBBP
ENST00000382070.7
TSL:1
c.2670G>Ap.Pro890Pro
synonymous
Exon 13 of 30ENSP00000371502.3Q92793-2
CREBBP
ENST00000570939.2
TSL:5
c.1389G>Ap.Pro463Pro
synonymous
Exon 9 of 23ENSP00000461002.2I3L466

Frequencies

GnomAD3 genomes
AF:
0.0230
AC:
3492
AN:
152010
Hom.:
167
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0324
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.194
Gnomad SAS
AF:
0.118
Gnomad FIN
AF:
0.00189
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00307
Gnomad OTH
AF:
0.0206
GnomAD2 exomes
AF:
0.0346
AC:
8686
AN:
251184
AF XY:
0.0378
show subpopulations
Gnomad AFR exome
AF:
0.0323
Gnomad AMR exome
AF:
0.00969
Gnomad ASJ exome
AF:
0.00516
Gnomad EAS exome
AF:
0.203
Gnomad FIN exome
AF:
0.00158
Gnomad NFE exome
AF:
0.00339
Gnomad OTH exome
AF:
0.0220
GnomAD4 exome
AF:
0.0152
AC:
22175
AN:
1461764
Hom.:
1345
Cov.:
33
AF XY:
0.0180
AC XY:
13062
AN XY:
727200
show subpopulations
African (AFR)
AF:
0.0352
AC:
1177
AN:
33478
American (AMR)
AF:
0.0101
AC:
451
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00589
AC:
154
AN:
26136
East Asian (EAS)
AF:
0.168
AC:
6670
AN:
39700
South Asian (SAS)
AF:
0.111
AC:
9614
AN:
86252
European-Finnish (FIN)
AF:
0.00219
AC:
117
AN:
53344
Middle Eastern (MID)
AF:
0.0237
AC:
136
AN:
5742
European-Non Finnish (NFE)
AF:
0.00213
AC:
2364
AN:
1111996
Other (OTH)
AF:
0.0247
AC:
1492
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1410
2820
4230
5640
7050
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
330
660
990
1320
1650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0230
AC:
3493
AN:
152126
Hom.:
168
Cov.:
31
AF XY:
0.0256
AC XY:
1902
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.0324
AC:
1345
AN:
41498
American (AMR)
AF:
0.0158
AC:
242
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3470
East Asian (EAS)
AF:
0.195
AC:
1005
AN:
5162
South Asian (SAS)
AF:
0.117
AC:
564
AN:
4814
European-Finnish (FIN)
AF:
0.00189
AC:
20
AN:
10598
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.00307
AC:
209
AN:
67988
Other (OTH)
AF:
0.0203
AC:
43
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
151
302
452
603
754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00912
Hom.:
8
Bravo
AF:
0.0237
Asia WGS
AF:
0.141
AC:
489
AN:
3478
EpiCase
AF:
0.00414
EpiControl
AF:
0.00350

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
0.44
DANN
Benign
0.58
PhyloP100
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3025694; hg19: chr16-3820667; COSMIC: COSV52117511; COSMIC: COSV52117511; API